[Duration of antivitamin K therapy in venous thromboembolic disease. Certainties and uncertainties].

MLA

Ferrari, E., et al. “[Duration of Antivitamin K Therapy in Venous Thromboembolic Disease. Certainties and Uncertainties].” Archives Des Maladies Du Coeur et Des Vaisseaux, vol. 94, no. 11 Suppl, Nov. 2001, pp. 1301–06. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=11794973&authtype=sso&custid=ns315887.

APA

Ferrari, E., Schiano, N., Benhamou, M., & Baudouy, M. (2001). [Duration of antivitamin K therapy in venous thromboembolic disease. Certainties and uncertainties]. Archives Des Maladies Du Coeur et Des Vaisseaux, 94(11 Suppl), 1301–1306.

Chicago

Ferrari, E, N Schiano, M Benhamou, and M Baudouy. 2001. “[Duration of Antivitamin K Therapy in Venous Thromboembolic Disease. Certainties and Uncertainties].” Archives Des Maladies Du Coeur et Des Vaisseaux 94 (11 Suppl): 1301–6. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=11794973&authtype=sso&custid=ns315887.